心房細動患者の出血リスクにおける人種差異:韓国と英国の人口を比較した生態学的疫学研究
Dongseon Kang1,2, Pil-Sung Yang3, Daehoon Kim4
1Cardiology, Yonsei University College of Medicine, Seodaemun-gu, Korea (the Republic of).
Thrombosis and haemostasis
|August 26, 2025
まとめ
白人のヨーロッパ人より血出のリスクは全体的に低いが,頭蓋内出血のリスクは高い. 人種と抗血栓薬の使用を考慮して 合わせたアプローチが必要である.
科学分野:
- 心臓病科
- 流行病学
- ファルマゲノミクス
背景:
- 血出のリスクは人種差異があり,アジア系の人口は潜在的により高いリスクに直面しています.
- 心房細動 (AF) の管理には,出血の合併症を慎重に検討する必要があります.
研究 の 目的:
- 心房細動 (AF) の患者における出血リスクの人種差を調査する.
- 東アジアと白人のヨーロッパ人のAF患者の出血結果を比較するために,生態学的疫学的なアプローチを使用する.
主な方法:
- 韓国国民健康保険サービス-健康スクリーニングと英国バイオバンクからのAF患者の分析 (2006年−2010年).
- 1928人の東アジア人,5917人の白人ヨーロッパ人を含む.
- 主なアウトカム:頭蓋内出血および胃腸,呼吸器,尿器系からの出血.
主要な成果:
- 東アジア人は,白人のヨーロッパ人と比較して,5年経過した最初の結果の発生率が42%低かった (IRR0.58).
- 東アジア人は頭蓋内出血の発生率が高い傾向を示した (IRR2. 36).
- 抗血栓剤投与前の患者では差異が持続し,抗血栓剤投与を受けた東アジア人および白人ヨーロッパ人の主な結果には有意な差異はなかった.
結論:
- 血行部位によるAF関連出血の有意な人種差異がある.
- 抗血栓薬の使用は出血のリスクを変化させ,人種に基づく個別化された治療戦略を必要とします.
関連する概念動画
Disorders of Hemostasis
1.2K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.2K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.3K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K
Venous Thrombosis IV: Nursing Management
23
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
23
Venous Thrombosis III: Interprofessional Care
22
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
22
Bias in Epidemiological Studies
675
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
675


